July 25, 2008
Task Force Recommends Against PSA Screening for Older Men

WASHINGTON, Aug. 4 -- PSA screening at age 75 and older has a negligible benefit at best, according to the U.S. Preventive Services Task Force, which has recommended against doing it.     <READ MORE>

July 25, 2008
Early Findings Create Buzz for Potent Novel Hormone Blocker

LONDON, July 25 -- Abiraterone, a novel, potent hormone-blocker, appears to be safe for treatment of castration-resistant prostate cancer, researchers here reported.     <READ MORE>

July 10, 2008
Prostate Cancer Vaccine Before Hormones May Boost Survival

BETHESDA, Md., July 10 -- For nonmetastatic castration-resistant prostate cancer, an investigational poxvirus-based PSA vaccine given before second-line hormone therapy, rather than the reverse approach, might confer a survival advantage, researchers here found.      <READ MORE>

July 8, 2008
No Survival Benefit in Androgen Deprivation for Prostate Cancer

NEW BRUNSWICK, N.J., July 8 -- Primary androgen deprivation therapy offers no survival benefit to older men with localized prostate cancer, according to a review of Medicare data.     <READ MORE>

May 29, 2008
Estrogen Plays a Role in Prostate Cancer

NEW YORK, May 29 -- An aggressive form of prostate cancer appears to be regulated through an estrogen-receptor-dependent mechanism, researchers found.      <READ MORE>

May 28, 2008
AUA: Studies Link Cholesterol to Prostate Cancer Recurrence

ORLANDO, May 28 -- Controlling serum cholesterol may help reduce the risk of prostate cancer as well as heart disease, two studies reported here suggest.      <READ MORE>

May 23, 2008
AUA: PSA Testing Might Not Be Necessary for Older Men

ORLANDO, May 23 -- At age 75, men who have PSA levels less than 3 ng/mL can safely discontinue routine prostate cancer screening because they have a low risk of developing aggressive disease, data from a large prospective cohort study suggest.     <READ MORE>

May 20, 2008
AUA: Active Surveillance Still Viable for Some Prostate Cancer Patients

ORLANDO, May 20 -- For men with low-risk, localized prostate cancer, active surveillance remains a viable option, but not without a "small but very real" risk, new data suggest.     <READ MORE>

May 19, 2008
MedPage Today News: AUA: Prostate Cancer Vaccine Linked to Improved Survival in Small Trial

ORLANDO, May 19 -- More than half of men with metastatic, hormone-refractory prostate cancer had longer-than-estimated survival after treatment with an adenovirus/PSA vaccine, showed a phase I study.     <READ MORE>

May 01, 2008
Gene Expression May Identify High-Risk Prostate Neoplasia

BARCELONA, Spain, May 1 -- The risk that high-grade prostatic intraepithelial neoplasia will turn malignant may stem from overexpression of a prostate tumor gene, found investigators here.     <READ MORE>

Apr 18, 2008
AACR: Statin-COX2 Inhibitor Combo Slows Prostate Cancer Growth

SAN DIEGO, April 18 -- Progression of androgen-independent prostate cancer was significantly inhibited in mice by a combination of atorvastatin (Lipitor) and celecoxib (Celebrex), according to a study reported here.     <READ MORE>

Mar 19, 2008
Global Look at Fallout from Prostate Cancer Therapy Reveals Buried Troubles 

BOSTON, March 19 -- Sexual dysfunction and incontinence seem to be only the better known quality-of-life downsides of therapy for prostate cancer, according to researchers here.     <READ MORE>

Feb 29, 2008
Angiogenesis Protein Helps Detect Prostate Cancer Nodal Status 

DALLAS, Feb. 29 -- Nodal involvement in localized prostate cancer can be detected with near 100% accuracy prior to a prostatectomy by adding measurement of the angiogenesis modulator endoglin to a predictive model, investigators here reported.     <READ MORE>

Feb 19, 2008
PSA Levels Deceptively Low in Obese Men 

DURHAM, N.C., Feb. 19 -- Obesity may hide early evidence of prostate cancer by lowering prostate-specific antigen levels, according to a community-based screening study.    <READ MORE>

Feb 18, 2008
ASCO GU: Bisphosphonate Effective Long Term in Prostate Cancer Hormone Therapy

SAN FRANCISCO, Feb. 18 -- Zoledronic acid (Zometa) improves bone mineral density in long-term use during androgen suppression therapy for prostate cancer, researchers found.   <READ MORE>

Feb 15, 2008
PSA Test Before Age 50 May Predict Advanced Cancer 25 Years Later 

NEW YORK, Feb. 15 -- A single PSA test -- taken before the age of 50 -- can predict a diagnosis of advanced prostate cancer up to 25 years later, according to researchers here and in Sweden.   <READ MORE>

Feb 15, 2008
ASCO GU: Immediate Androgen Suppression Questioned for Node-Positive Prostate Cancer

SAN FRANCISCO, Feb. 15 -- Delaying hormone therapy for node-positive prostate cancer until disease progression may not impair survival, Dutch researchers found.    <READ MORE>

Feb 13, 2008
ASCO GU: Radiation Reduces Mortality Risk of Recurrent Prostate Cancer

SAN FRANCISCO, Feb. 14 -- Radiotherapy improves survival for some men with rising prostate-specific antigen (PSA) levels after radical prostatectomy, researchers found.   <READ MORE>

Feb 13, 2008
ASCO GU: No Prostate Cancer Treatment Needed for Most Older Men

SAN FRANCISCO, Feb. 13 -- Watchful waiting may be safe for most older men with early-stage prostate cancer, researchers affirmed.   <READ MORE>

Jan 22, 2008
Comorbidity Can Confound Prostate Cancer Treatment

BOSTON, Jan. 22 -- The best-laid plans of therapy for localized unfavorable-risk prostate cancer can be upset by pre-existing comorbidities, investigators here found.   <READ MORE>

Jan 16, 2008
Prostate Cancer Risk Boosted by Gene Variations Plus Family History

BALTIMORE, Jan. 16 -- The risk of prostate cancer increases dramatically in the face of five common genetic variations as well as a family history, researchers here said.   <READ MORE>

Jan 15, 2008
Dietary Supplement Tied to Metastatic Prostate Cancer

DALLAS, Jan. 15 -- When two patients developed unusually aggressive metastatic prostate cancer within months of starting the same muscle-building dietary supplement, researchers here started investigating.  <READ MORE>

Jan 3, 2008
Short-Course Hormone Therapy Provides Years of Benefit in Prostate Cancer

SAN FRANCISCO, Jan. 3 -- Short-term neoadjuvant hormonal therapy may improve long-term prostate cancer outcomes for men with locally advanced, high-risk disease but unable to tolerate a standard course of androgen suppression.  <READ MORE>

Dec 27, 2007
Aspirin Therapy Can Impair Prostate Cancer Treatment

BOSTON, Dec. 27 -- Regular use of even low-dose aspirin may interfere with androgen suppression therapy for men with prostate cancer.  <READ MORE>

Nov 12, 2007
Family Program Helps Patients and Spouses Cope with Prostate Cancer

ANN ARBOR, Mich., Nov. 12 -- Family counseling improved the lives of prostate cancer patients and their spouses, with much of the benefit going to the care-giving spouse, researchers here reported.  <READ MORE>

Oct 31, 2007
ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men

LOS ANGELES, Oct. 31 -- Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.  <READ MORE>

Oct 29, 2007
ASTRO: Exercise Prevents Bone Loss from Prostate Cancer Androgen Deprivation

LOS ANGELES, Oct. 29 -- The bone loss associated with androgen deprivation therapy for prostate cancer, along with radiation treatment, can be prevented by a brisk walk five or six times a week, a researcher said here.  <READ MORE>

Sept 17, 2007
DOD Prostate: Barbers Cut to the Chase in Minority Prostate Cancer Awareness

ATLANTA, Sept. 17 -- Attacking locally advanced prostate cancer with intermittent androgen treatment may improve quality of life while maintaining the historical survival of more aggressive therapy.  <READ MORE>

Sept 7, 2007
DOD Prostate: Barbers Cut to the Chase in Minority Prostate Cancer Awareness

ATLANTA, Sept. 7 -- Although barbers and surgeons have long been linked in the history of medicine, the role of urologist's assistant is a new twist. Now the barbershop is becoming a clearinghouse for minority prostate cancer screening.  <READ MORE>

August 20, 2007
Robotic-Assisted Laparoscopic Prostatectomy Speeds Recovery

CHAPEL HILL, N.C., Aug. 20 -- A robotic-assisted laparoscopic prostatectomy seems to lead to a faster surgical recovery than an open procedure, found investigators here.  <READ MORE>

August 1, 2007
Prostate Cancer Viewed as Condition Linked to Fused Chromosomes

ANN ARBOR, Mich., Aug. 1 -- Prostate cancer may be an umbrella term for a variety of neoplastic conditions traced to fused chromosomes, according to genetic findings here.  <READ MORE>

July 25, 2007
Recurrence Risk after Prostatectomy Lower with Experienced Surgeons

NEW YORK, July 25 -- For clinically localized prostate cancer, the experience of the surgeon doing a radical prostatectomy may play a major role in avoiding a biochemical relapse, according to investigators here.  <READ MORE>

August 15, 2007
Elevated Immune Protein May Identify High-Risk Prostate Cancer

ROCHESTER, Minn., Aug. 15 -- Aggressive, high-risk prostate cancers have increased expression of an immumodulatory protein that predicts relapse after treatment, investigators reported.  <READ MORE>

July 25, 2007
Recurrence Risk after Prostatectomy Lower with Experienced Surgeons

NEW YORK, July 25 -- For clinically localized prostate cancer, the experience of the surgeon doing a radical prostatectomy may play a major role in avoiding a biochemical relapse, according to investigators here.  <READ MORE>

April 26, 2007
Hopkins Researchers Find a Better Blood Test For Prostate Cancer

New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.  <READ MORE>